What Are the Risks If Genetic CPP Is Untreated in Girls?

Genetic central precocious puberty (CPP) occurs when the brain prematurely activates the hormone pathway that signals the ovaries to start puberty, often due to an inherited gene variation (such as an MKRN3 mutation). When families consider whether to use puberty-suppressing GnRH agonist treatment, they must weigh the medication against the risks of letting puberty progress.

If you choose not to treat genetic CPP, the primary physical risk is that your daughter’s growth plates may close too early, resulting in a reduced final adult height potential ^[1]. She will also continue to go through progressive physical changes, including noticeable breast development and starting her period (menses) much earlier than her peers ^[2]. While many parents worry about the emotional toll of early maturation, research shows that psychological harm is not inevitable ^[3].

Premature Bone Fusion and Adult Height

In girls with CPP, the body produces pubertal levels of hormones earlier than expected. The hormones responsible for the pubertal growth spurt also eventually tell the growth plates in the bones to fuse and stop growing ^[4].

Without puberty-suppressing treatment, a girl with progressive CPP will typically grow very fast early on ^[5]. However, because her skeletal maturation (bone age) is advanced, her growth plates may close prematurely ^[1]. This compromised adult height potential is the most well-established medical risk of untreated CPP ^[6].

Importantly, a significantly shorter final height is a risk, not an absolute certainty for every child ^[7]. Some untreated girls still reach a normal adult height or match their genetic target height based on their parents’ heights ^[8]. The exact risk depends heavily on her age at onset, how quickly puberty is progressing, and her current bone age. While genetic causes like MKRN3 mutations can lead to rapid bone age advancement, individual progression varies and should be closely monitored and interpreted by a pediatric endocrinologist ^[9].

Progressive Physical Changes

If left untreated, central precocious puberty does not stop at early breast budding; the entire reproductive system continues to mature ^[10]. Your daughter will continue to progress through the physical stages of puberty at an accelerated rate ^[2].

This means many girls will eventually begin menstruating (having periods) early. One study following girls with untreated idiopathic CPP estimated spontaneous menarche occurred at an average age of 10.1 years ^[11]. However, exact timing varies widely from child to child. Families choosing observation must be prepared to help a young child manage menstruation. This includes practical preparation at home, coordinating with school staff, and knowing when to contact a doctor about irregular or heavy bleeding.

Emotional and Psychological Impact

A major reason parents consider treatment is to protect their child from the social and psychological distress of developing before their peers ^[12]. Large registry studies have shown an association between precocious puberty and higher subsequent rates of psychiatric diagnoses ^[13], and some smaller studies note a lower health-related quality of life ^[14].

However, these studies show an association, not definitive proof that early puberty causes these diagnoses, and it is not established that GnRH treatment guarantees the prevention of future psychological distress ^[12]. In fact, studies comparing untreated girls with early puberty to those with normal-timing puberty have sometimes found no measurable difference in baseline psychological adjustment ^[3].

Much of a child’s emotional well-being relates to her environment. Family stress is associated with behavioral challenges in girls experiencing early puberty, while strong, supportive environments can reduce anxiety and stress ^[15]. While the social challenges of developing early are real, they can often be navigated with robust emotional support and open communication.

Observation and Monitoring

If you decline or delay treatment, it is critical to continue structured follow-up with a pediatric endocrinologist. Monitoring typically involves regular clinic visits to track growth velocity, physical pubertal changes, and periodic X-rays to check bone age. This observation ensures your care team can detect rapid progression and allows you to revisit the treatment decision if necessary, though monitoring alone cannot guarantee that height potential is preserved.